Medline (MDLN) Total Non-Current Liabilities (2024 - 2026)

Medline (MDLN) has 3 years of Total Non-Current Liabilities data on file, last reported at $17.1 billion in Q1 2026.

• Quarterly Total Non-Current Liabilities changed N/A year-over-year to $17.1 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $17.1 billion (changed N/A YoY) and the FY2025 annual result came in at $16.7 billion, down 1.8% from the prior year.
• Total Non-Current Liabilities rose to $17.1 billion in Q1 2026 per MDLN's latest filing, from $16.7 billion in the prior quarter.
• Across five years, Total Non-Current Liabilities topped out at $17.1 billion in Q1 2026 and bottomed at $16.7 billion in Q4 2025.
• The 3-year median for Total Non-Current Liabilities is $17.0 billion (2024), against an average of $17.0 billion.
• Peak annual rise in Total Non-Current Liabilities reached 1.8% in 2025, while the deepest fall reached 1.8% in 2025.
• Tracing MDLN's Total Non-Current Liabilities over 3 years: stood at $17.0 billion in 2024, then dropped by 1.8% to $16.7 billion in 2025, then increased by 2.52% to $17.1 billion in 2026.
• Per Business Quant, the three latest MDLN Total Non-Current Liabilities figures stand at $17.1 billion (Q1 2026), $16.7 billion (Q4 2025), and $17.0 billion (Q4 2024).

Peer Comparison